剑桥大学、都柏林大学2023最新PhD招生和奖学金信息

本期为大家推荐剑桥大学、都柏林大学2023最新奖学金介绍。

01、剑桥大学

Predicting the Evolution of Influenza and SARS-CoV-2 Viruses

University of Cambridge  Department of Zoology

博导:Prof D Smith, Prof H Baylis

截止日期:全年可申

资助的博士项目(全球学生)

项目描述:

About the Project

Our research focus is to design and develop analytical, computational, and mathematical methods to understand the fundamental processes that govern the evolution of influenza and SARS-CoV-2 viruses. In addition to the basic science core of the work, there is also the opportunity to translate this understanding into the prediction of future antigenic variants to guide phase II clinical trials of next generation influenza vaccines. Our research is highly interdisciplinary and involves substantial global collaboration with experimental virologists, immunologists and clinicians to quantify the selection pressures on influenza viruses in order to better understand their evolutionary dynamics, and to inform control strategies.

What the student will be doing:

The work in our group is theoretical and computational, in collaboration with experimental partners. Though this project is primarily computational, our group collaborates closely with experimental partners worldwide, e.g., Erasmus Medical Centre in the Netherlands and the University of Wisconsin in the United States.

Supervisor: Derek Smith

Derek Smith is Professor of Infectious Disease Informatics in the Zoology Department at Cambridge University. He is an advisor to the WHO influenza vaccine strain selection committee, and is also involved in vaccine strain selection for other human and non-human pathogens for the United Nations Food and Agriculture Organization and the World Animal Health Organisation. 

Derek’s research focuses on how pathogens evolve, to what extent this evolution is predictable, and determining public and animal health measures against such ever-changing pathogens. His group has developed vital computational tools for analysis and interpretation of antigenic variation and antibody responses to influenza and SARS-CoV-2. He has a long-standing interest in the effects of prior immunity and repeated vaccination. The combination of extensive knowledge of SARS-CoV-2 epidemiology and immunology with novel modelling and computational analyses has enabled him to answer fundamental questions about virus evolution and antibody mediated protection. During the COVID pandemic Derek contributed to SAGE, the UK Government Scientific Advisory Group for Emergencies and is a member of the US Government NIH SARS-CoV-2 Assessment of Viral Evolution (SAVE) Program.

02、都柏林大学

PhD in Chemistry / Biomaterials at University College Dublin in collaboration with Blafar Ltd.

University College Dublin | Charles Institute of Dermatology

博导:Prof Wenxin Wang

截止日期:全年可申

资助的博士项目(全球学生)

项目描述:

About the Project

Overview of the Post:

Blafar Ltd. and Prof Wenxin Wang’s Lab, located in University College Dublin (UCD) in Ireland, is seeking motivated, passionate candidates to embark on PhD doctoral studies in Polymer Chemistry / Chemistry / Biomaterials Engineering / Biomedical Engineering / Chemical Engineering / Biochemistry or a related field.

Organization: Blafar Ltd. and University College Dublin (UCD)

Workplace: Blafar Ltd., (NovaUCD, Belfield Innovation Park, Dublin, D04 V2P1, Ireland); Prof. Wenxin Wang’s lab, (The Charles Institute of Dermatology, School of Medicine, UCD, Ireland).

Post Treatment and Cultivation Mode: This is a 4-year full-time position, with a stipend of €18,000 per annum and PhD fee contribution of €14,700 per annum. PhD students are encouraged to conduct collaborative research studies with internationally renowned research groups and R&D enterprises in their research field in order to develop new knowledge, techniques, and technologies.

Research Field: Polymer Chemistry / Chemistry / Biomaterials Engineering / Biomedical Engineering / Chemical Engineering / Biochemistry or a related field.

Blafar Ltd. Website: https://blafar.com/

Group Website: http://www.wenxinwang.group/

Introduction to Blafar Ltd.:

Blafar Ltd. Vision and Mission: To design and deliver advanced biomaterial solutions for our global customers.

Blafar Ltd. has the expertise, knowledge and technologies in the design, development and manufacture of functionalised biopolymers, injectable hydrogels, and bio-inks from multifunctional ECM-based and synthetic biopolymers for cosmetic, pharmaceutical, and medical applications, such as medical aesthetics, the delivery of stem cells/drugs, and 3D bioprinting.  

Currently, the functionalised biopolymer product portfolio includes hyperbranched (HB) PEG-based polymers, functionalised hyaluronic acid (HA), collagen, gelatin, chondroitin sulfate (CS) and their derived biocompatible and customisable hydrogels and bio-inks. The goal is to achieve the leadership position in the functionalised biopolymers market by developing and manufacturing biopolymer products as key functional ingredients as well as developing end-use products including injectable hydrogels for cell/drug delivery and bio-inks for 3D bioprinting.

Blafar Ltd. is proud to develop and maintain industry-academia research partnerships to advance high-impact research for biopolymer products.

Introduction to Prof Wenxin Wang and Wang’s lab:

Prof. Wenxin Wang is currently a Full Professor at the Charles Institute of Dermatology, School of Medicine, University College Dublin (UCD), a member of UCD Academic Council, and a Guest Professor at the Department of Polymer Science and Engineering, Zhejiang University, China. Prof. Wang and his research group have long been engaged in the research of controlled polymerization mechanisms, and the design and synthesis of novel functional biomaterials and their applications in bone, cartilage, and skin wound healing.

Prof. Wang’s scientific contributions and achievements have been recognized extensively at the global level reflected in 216 peer-reviewed scientific journal papers (Science Advances, Nature Communications, Nature Reviews Chemistry, JACS, Angewandte Chemie, Advanced Materials, Nano Letters, Macromolecules, etc.), 5 book chapters, 34 patents, 140 conference abstracts and presentations, and 116 invited lectures and keynote presentations. His achievements have met the increased interest in the wider public community with publicity media activities (engaging 56 times in TV Documentary, Videos and Newspapers), for example in RTE, ‘The Sunday Times’, ‘The Irish Times’, ‘Science Daily’ and ‘Chemistry World’. As the founder, Prof Wang has launched 3 companies - Vornia Ltd (www.vornia.com, sold to Ashland - a Fortune500 US company in Jan. 2018, renamed as Ashland Specialties Ireland), Blafar Ltd (www.blafar.com), Branca Bunus Ltd (www.brancabunus.com). Furthermore, he has licensed 17 new technologies to 5 companies, and successfully launched and commercialized 5 newly developed technologies onto the market.

Prof. Wang’s group possesses abundant scientific research funds, complete facilities and well-established platforms for polymer simulation, synthesis, characterization, and related application studies. The research group also has long-term academic exchanges and collaborative relationships with the Top universities in the world, e.g. Harvard University, MIT, Stanford University, University of Cambridge etc. Among the graduated PhD students, many of them have got Postdoc fellowships in Worldwide Top universities (e.g., Harvard University, University of Cambridge, Stanford University, University of Washington, and University of Nottingham etc.), In addition, currently, more than 10 of the Postdocs and Scientific Researchers supervised by Prof. Wang have been appointed as (associated) Professor in renowned universities (e.g., University College London, Cardiff University, Sun Yat-Sen University, Zhejiang University, Tianjin University and Xi’an Jiaotong University, etc.), or developed their career in internationally well-known enterprises (such as McKinsey & Company - the world's largest strategic consultancy, Ashland - a Fortune500 US company, etc.).

Post Requirements:

  1. Minimum of an upper second-class honours degree (or equivalent) in Polymer Chemistry / Chemistry / Biomaterials Engineering / Biomedical Engineering / Chemical Engineering / Biochemistry or other related fields.
  2. A strong passion for science, particularly in the development of functionalised materials for biomedical applications.
  3. A high level of competence in the English language. UCD's minimum English language requirements: An average score of 6.5 over all components and a minimum of 6.0 in each band on the Academic Version/A minimum score of 90 is required in the Internet-based TOEFL (iBT) with a score of at least 20 in each section/ Due to COVID-19, UCD has approved the use of the Duolingo English Test (DET) as a temporary measure for the 2022 intake. The minimum requirement will be a DET score of 110.
  4. Highly motivated, driven, creative, conscientious, and have the ability to work independently and integrate as part of a team.
  5. Healthy, kind, nice, decent, honest, and hard-working.

We are committed to cultivating a group of high-quality talents who are truly passionate about the field of polymeric science and advanced biotechnology. From fundamental science to technology transfer and commercialization, the team is dedicated to bringing techniques to industrial and medical applications that benefit society.

We warmly and sincerely welcome new blood to join our big family!

Application procedure:

If you would like to apply, please send your CV and Personal Statement to wenxin.wang@ucd.ie and melissa.johnson@blafar.com with the subject line ‘PhD application’.

Your application will be judged openly and fairly. We will contact the short-listed candidates for preliminary assessment and following interviews as soon as possible

【竞赛报名/项目咨询请加微信:mollywei007】

下一篇

9月21日开放申请!加拿大本科OUAC这些大变动你知道了吗?

你也可能喜欢

  • 暂无相关文章!

评论已经被关闭。

插入图片
返回顶部